- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06364059
A Comparative Analysis of Prognostic Factors for Functional Outcomes in Patients With Acute Subdural Hematoma
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Ilona Trtíková, Mgr., Ph.D.
- Phone Number: +420 224 96 5602
- Email: Ilona.Trtikova@lf1.cuni.cz
Study Locations
-
-
-
Praha, Czechia, 16209
- Recruiting
- Military University Hospital Prague
-
Contact:
- Michal Soták, M.D., Ph.D.
- Phone Number: +420973202999
- Email: michal.sotak@uvn.cz
-
Principal Investigator:
- Tomáš Tyll, M.D., Ph.D.
-
Contact:
- Tomáš Tyll, M.D., Ph.D.
- Phone Number: +420973202999
- Email: tomas.tyll@uvn.cz
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- surgery due to ASDH
- 12 months of follow-up
- functional outcome measured by the Glasgow Outcome Scale Extended (GOSE).
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Surgery Group
Adult patients who underwent surgery due to acute subdural hematoma
|
Adult patients who underwent decompressive craniectomy with evacuation of subdural hematoma.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Level of consciousness at time of injury
Time Frame: through study completion, an average of 1 year
|
The level of consciousness (using the Glasgow Coma Scale, 3-15 points, higher score means a better outcome) at the time of injury is analyzed.
|
through study completion, an average of 1 year
|
Initial size of subdural hematoma
Time Frame: through study completion, an average of 1 year
|
Initial size of subdural hematoma measured in millimetres using CT scan.
|
through study completion, an average of 1 year
|
Initial midline shift
Time Frame: through study completion, an average of 1 year
|
Initial size of midline shift measured in millimetres using CT scan.
|
through study completion, an average of 1 year
|
Chronic use of anti-clotting medication
Time Frame: once at time of admission
|
The number of patients on chronic anticoagulation therapy will be the subject of analysis.
|
once at time of admission
|
Trauma severity analyzed using Injury Severity Score (ISS).
Time Frame: once at time of admission
|
Trauma severity analyzed using Injury Severity Score.
The ISS scores ranges from 1 to 75 points (Higher scores correspond to more severe injury and a higher risk of death).
|
once at time of admission
|
Severity of illness analyzed using Acute Physiology and Chronic Health Evaluation II score (APACHE II)
Time Frame: within 24 hours of admission
|
Severity of patient illness will be analyzed using Acute Physiology and Chronic Health Evaluation II score (APACHE II) which ranges from 0 to 71 points.
Higher scores correspond to more severe disease and a higher risk of death.
|
within 24 hours of admission
|
The Glasgow Outcome Scale (GOS) at the time of discharge from the Intensive Care (IC).
Time Frame: through study completion, an average of 1 year
|
The Glasgow Outcome Score allowing the objective assessment of the patient´s recovery after trauma brain injury.
Allows a prediction of the long-term course of rehabilitation to return to work and everyday life.
It uses five categories: 1. Death, 2. Persistent vegetative state, 3. Severe disability, 4. Moderate disability, 5. Low disability.
|
through study completion, an average of 1 year
|
The Glasgow Outcome Scale Extended (GOSE) evaluation of global disability and recovery after 6 months.
Time Frame: 6 months follow up
|
The Glasgow Outcome Scale Extended (GOSE) is an expanded version of the Glasgow Outcome Scale for evaluation of global disability and recovery after traumatic brain injury. It uses eight categories: 1. Death, 2. Vegetative state, 3. Lower severe disability, 4. Upper severe disability, 5. Lower moderate disability, 6. Upper moderate disability - some disability but can potentially return to some form of employment, 7. Lower good recovery - minor physical or mental defect, 8. Upper good recovery - full recovery. A GOSE analysis will be performed on a patient who has undergone evacuation of a subdural hematoma 6 months after the trauma. |
6 months follow up
|
The Glasgow Outcome Scale Extended (GOSE) evaluation of global disability and recovery after 12 months.
Time Frame: 12 months follow up
|
The Glasgow Outcome Scale Extended (GOSE) is an expanded version of the Glasgow Outcome Scale for evaluation of global disability and recovery after traumatic brain injury. It uses eight categories: 1. Death, 2. Vegetative state, 3. Lower severe disability, 4. Upper severe disability, 5. Lower moderate disability, 6. Upper moderate disability - some disability but can potentially return to some form of employment, 7. Lower good recovery - minor physical or mental defect, 8. Upper good recovery - full recovery. A GOSE analysis will be performed on a patient who has undergone evacuation of a subdural hematoma 12 months after the trauma. |
12 months follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of revisions.
Time Frame: 24 hours
|
The number of re-operations that are required within 24 hours of the initial procedure will be analyzed.
|
24 hours
|
Time from injury to surgery.
Time Frame: 24 hours
|
The time from the onset of the injury to the evacuation of the subdural hematoma will be analyzed.
|
24 hours
|
Time of operation.
Time Frame: up to 4 hours
|
The operative time of the evacuation of the subdural hematoma will be analyzed.
|
up to 4 hours
|
The need for reversal of the effects of anticoagulants.
Time Frame: 24 hours
|
The number of cases of need for reversal of the effect of chronic anticoagulant medication will be analyzed.
|
24 hours
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Tomáš Tyll, M.D., Ph.D., Charles University, Czech Republic
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Wounds and Injuries
- Hemorrhage
- Craniocerebral Trauma
- Trauma, Nervous System
- Intracranial Hemorrhages
- Intracranial Hemorrhage, Traumatic
- Brain Injuries
- Hematoma
- Hematoma, Subdural
- Hematoma, Subdural, Acute
Other Study ID Numbers
- aSDH-TT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acquired Brain Injury
-
University of ValenciaRecruiting
-
The University of Texas Health Science Center,...TerminatedAcquired Brain InjuryUnited States
-
IRCCS Eugenio MedeaRegione Lombardia; National Research Council of ItalyCompletedAcquired Brain InjuryItaly
-
Hopitaux de Saint-MauriceInstitut National de la Santé Et de la Recherche Médicale, France; Ministry... and other collaboratorsCompleted
-
Manchester University NHS Foundation TrustUniversity of SalfordCompletedAcquired Brain InjuryUnited Kingdom
-
University of ManitobaHealth Sciences Centre Foundation, ManitobaCompletedAcquired Brain InjuryCanada
-
Intendu Ltd.Tel Aviv University; Sheba Medical Center; Loewenstein HospitalUnknownAcquired Brain InjuryIsrael
-
MinYoung Kim, M.D.Completed
-
Children's Hospital Medical Center, CincinnatiEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedBrain Injuries | Traumatic Brain Injury | Acquired Brain InjuryUnited States
-
Virginia Commonwealth UniversityDepartment of Health and Human ServicesCompletedTraumatic Brain Injury | Acquired Brain InjuryUnited States
Clinical Trials on Decompressive craniectomy with evacuation of subdural hematoma
-
Assiut UniversityUnknownTraumatic Brain Hemorrhage
-
Assiut UniversityNot yet recruiting
-
Dartmouth-Hitchcock Medical CenterCompletedChronic Subdural Hematoma | Subdural HematomaUnited States
-
The Affiliated Hospital Of Guizhou Medical UniversityRecruiting
-
Chinese PLA General HospitalThe First Affiliated Hospital of Nanchang University; First Affiliated Hospital... and other collaboratorsCompletedIntracranial Hemorrhage, HypertensiveChina
-
Kwong Wah HospitalUnknownChronic Subdural Hematoma | Subdural DrainChina
-
Assiut UniversityNot yet recruitingExtradural Hematoma
-
Chinese Academy of SciencesAffiliated Hospital of Logistics University of CAPFUnknown
-
M.D. Anderson Cancer CenterSchering-PloughCompletedCarcinoma, Squamous Cell | Cancer of Head and NeckUnited States
-
Region SkaneKarolinska University Hospital; Lund University; Sahlgrenska University Hospital... and other collaboratorsRecruitingChronic Subdural HematomaSweden